Sclerostin loss‐of‐function is associated with sclerosteosis (OMIM# 269500) and dysregulation of sclerostin has been linked to Van Buchem Disease (OMIM# 239100), disorders of skeletal overgrowth. The gene discussed is SOST; the disease is hyperostosis corticalis generalisata.